Editorial
Something in need is something indeed
Translational Lung Cancer Research
2012;
1
(1)
:1-2
.
(18 February 2012)
Research Highlight
EGFR-TKIs in EGFR-mutated lung cancer: setting the new standard for 1st line therapy
Translational Lung Cancer Research
2012;
1
(1)
:3-4
.
(18 February 2012)
Review Articles
Advances on EGFR mutation for lung cancer
Translational Lung Cancer Research
2012;
1
(1)
:5-13
.
(18 February 2012)
Angiogenesis in cancer: anti-VEGF escape mechanisms
Translational Lung Cancer Research
2012;
1
(1)
:14-25
.
(18 February 2012)
Statistical considerations and endpoints for clinical lung cancer studies: can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?
Translational Lung Cancer Research
2012;
1
(1)
:26-35
.
(18 February 2012)
Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review
Translational Lung Cancer Research
2012;
1
(1)
:36-44
.
(18 February 2012)
Are three doses of SABR (stereotactic ablative radiotherapy) more effective than 30 doses of conventional radiotherapy?
Translational Lung Cancer Research
2012;
1
(1)
:45-53
.
(18 February 2012)
Cetuximab in non-small-cell lung cancer
Translational Lung Cancer Research
2012;
1
(1)
:54-60
.
(18 February 2012)
Perspectives
Chemotherapy of lung cancer: a global perspective of the role of ifosfamide
Translational Lung Cancer Research
2012;
1
(1)
:61-71
.
(18 February 2012)
Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy
Translational Lung Cancer Research
2012;
1
(1)
:72-77
.
(18 February 2012)
Functional CT imaging techniques for the assessment of angiogenesis in lung cancer
Translational Lung Cancer Research
2012;
1
(1)
:78-83
.
(18 February 2012)
Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis
Translational Lung Cancer Research
2012;
1
(1)
:84-88
.
(18 February 2012)
Short Communication
Conflict-Management within clinical and administrative stakeholders in medical structures
Translational Lung Cancer Research
2012;
1
(1)
:89-90
.
(18 February 2012)
Correspondence
Status quo and prospects of the translational research on lung cancer in China
Translational Lung Cancer Research
2012;
1
(1)
:91-93
.
(18 February 2012)
